Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to

V Boss1, J D Roback, A N Young

  • 1Departments of Pharmacology and Pathology, Emory University School of Medicine, Atlanta, Georgia 30329, USA.

Insights

Nerve growth factor (NGF) and epidermal growth factor (EGF) trigger distinct cellular responses. Researchers identified a specific protein complex, Fra-2/JunD, activated by NGF but not EGF, suggesting its role in NGF-driven gene expression.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Nerve growth factor (NGF) and epidermal growth factor (EGF) activate similar signaling pathways in pheochromocytoma (PC12) cells.
  • Despite pathway similarity, NGF induces differentiation, while EGF promotes cell proliferation (mitogenesis).
  • Understanding the molecular basis for these divergent outcomes is crucial for cell signaling research.

Purpose of the Study:

  • To identify transcription factor activities unique to NGF signaling compared to EGF signaling.
  • To elucidate the specific molecular mechanisms underlying NGF-induced differentiation versus EGF-induced mitogenesis.
  • To characterize novel protein-DNA interactions in response to growth factor stimulation.

Main Methods:

  • Utilized a DNA recognition library with random oligonucleotide clones to isolate specific DNA-binding proteins from PC12 nuclear extracts.
  • Employed gel mobility shift assays and supershift assays to identify protein complexes and their DNA-binding partners.
  • Conducted time course experiments analyzing ERK phosphorylation, c-fos induction, and Fra-1/Fra-2 protein levels via Western blotting.

Main Results:

  • Identified a protein complex, Fra-2/JunD, with increased DNA binding activity specifically in NGF-treated cells, but not in EGF-treated cells.
  • Observed that NGF elicits a more delayed and sustained ERK phosphorylation compared to EGF.
  • NGF specifically increases Fra-1 and Fra-2 levels, with enhanced phosphorylation of Fra-2, suggesting its critical role in NGF signaling.

Conclusions:

  • Prolonged alterations in Fra-2 levels and Fra-2/JunD complex formation are key to NGF-specific gene expression programs.
  • The Fra-2/JunD complex's binding to AP-1 and CREB elements may orchestrate NGF-driven differentiation.
  • These findings highlight distinct downstream signaling events differentiating NGF and EGF actions in PC12 cells.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...